Merck invests $110 million to expand production site in China
Company will expand the existing production site in Wuxi to significantly increase biopharma single-use assemblies and custom design capabilities
Company will expand the existing production site in Wuxi to significantly increase biopharma single-use assemblies and custom design capabilities
MilliporeSigma to become the first company to offer a fully integrated ecosystem for advanced process technologies
Adds to Merck’s growing global, multi-modality CDMO network, following newly formed CDMO business unit in Life Science
The contract award from the U.S. Department of Defense (DoD), on behalf of the U.S. Department of Health and Human Services, is part of an effort to ensure secure local supply and production capacity for critical products for pandemic preparedness
Subscribe To Our Newsletter & Stay Updated